Related Experiment Video
Updated: Feb 14, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
[Pathogenesis of chronic disorders of cerebral circulation]
P R Kamchatnov1, A V Chugunov1, A A Tyazhelnikov2
1Pirogov Russian National Research Medical University, Moscow, Russia.
Insights
Chronic cerebrovascular disorders involve artery changes and impaired blood flow regulation. Nicergoline is being considered as a potential treatment to improve cerebral blood flow and autoregulation in affected patients.
Area of Science:
- Neurology
- Vascular Medicine
- Pharmacology
Background:
- Chronic disorders of cerebral circulation (CRMC) are prevalent conditions.
- Pathogenesis involves structural/functional changes in cerebral arteries and impaired autoregulation.
- Systemic arterial pressure also plays a crucial role.
Purpose of the Study:
- To evaluate the potential of nicergoline (Sermion) in treating patients with CRMC.
- To explore therapeutic options for improving cerebral blood flow and autoregulation.
Main Methods:
- Literature review on CRMC pathogenesis and treatments.
- Analysis of pharmacological properties of nicergoline.
- Consideration of clinical application in CRMC patients.
Main Results:
- Nicergoline is a drug that can increase cerebral blood flow.
- It has the potential to restore autoregulation of cerebral circulation.
- Its use is considered for patients suffering from CRMC.
Conclusions:
- Nicergoline shows promise as a therapeutic agent for CRMC.
- Further investigation into its efficacy and safety in CRMC patients is warranted.
- Improving cerebral blood flow and autoregulation is key in managing these disorders.
Abstract:
Chronic disorders of cerebral circulation are a common syndrome, in the pathogenesis of which the important role play structural and functional alterations in large and small arteries, autoregulation of cerebral circulation and the level of systemic arterial pressure. Drugs that increase cerebral blood flow and restore the ability to its autoregulation are used, among others, in treatment of patients with CRMC. The possibility of using nicergoline (sermion) for the treatment of patients with CRMK is considered.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...

